Secretion of activin A in recurrent epithelial ovarian carcinoma

Gynecologic Oncology

Volumn 74, Issue 1, 1999, Pages 93-97

  Lambert Messerlian, G M ^a   DePasquale, S E ^a   Maybruck, W M ^a   Steinhoff, M M ^a   Gajewski, W H ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Activin; CA 125; Ovarian cancer; Recurrent disease

Indexed keywords

ACTIVIN A;

ARTICLE; BLOOD LEVEL; CANCER REGRESSION; CLINICAL ARTICLE; CORRELATION FUNCTION; DIAGNOSTIC VALUE; FEMALE; HUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN SECRETION; RECURRENT CANCER;

EID: 0032773178     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5417     Document Type: Article

References (22)

1. Vale W, Rivier C, Hsueh A, Campen C, Meunier H, Bicsak T, Vaughan J, Corrigan A, Bardin W, Sawchenko P, Petraglia F, Yu J, Plotsky P, Spiess J, Rivier J. Chemical and biological characterization of the inhibin family of protein hormones. Rec Prog Horm Res. 44:1988;1-34.
2. Halvorsen L M, DeCherney A H. Inhibin, activin, and follistatin in reproductive medicine. Fertil Steril. 65:1996;459-469.
3. Welt C K, Lambert-Messerlian G, Zheng W, Crowley W F Jr., Schneyer A L. Presence of activin, inhibin and follistatin in epithelial ovarian cancer. J Clin Endocrinol Metab. 82:1997;3720-3727.
4. Zheng W, Sung C J, Hanna I, DePetris G, Lambert-Messerlian G, Steinhoff M, Lauchlan S C. α and β subunits of inhibin/activin as sex cord-stromal differentiation markers. Int J Gyn Pathol. 16:1997;263-271.
5. Zheng W, Luo M P, Welt C, Lambert-Messerlian G, Sung C J, Zhang Z, Ying S, Schneyer A L, Lauchlan S C, Felix J C. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer. Gynecol Oncol. 69:1998;23-31.
6. Arora D S, Cooke I E, Ganesan T S, Ramsdale J, Manek S, Charnock F ML, Groome N P, Wells M. Immunohistochemical expression of inhibin/activin subunits in epithelial and granulosa cell tumors of the ovary. J Pathol. 181:1997;413-418.
7. DiSimone N, Crowley W F, Wang Q F, Sluss P M, Schneyer A L. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: A potential role in autocrine growth regulation. Endocrinology. 137:1996;486-494.
8. Matzuk M M, Finegold M J, Mather J P, Krummen L, Lu L, Bradley A. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc Natl Acad Sci USA. 91:1994;8817-8821.
9. Matzuk M M, Finegold M J, Su J-G J, Hseuh A JW, Bradley A. Alpha inhibin is a tumor suppressor gene with gonadal specificity in mice. Nature. 360:1992;313-319.
10. Shikone T, Matzuk M M, Perlas E, Finegold M J, Lewis A K, Vale W, Bradley A, Hsueh A JW. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin alpha and p53-deficient mice: The role of activin as an autocrine growth factor. Mol Endocrinol. 8:1994;983-995.
11. Petraglia F, Luisi S, Sabourin J C, Rey R, Lhomme C, Bidart J M. Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors. J Clin Endocrinol Metab. 83:1998;1029-1032.
12. Knight P G, Muttukrishna S, Groome N P. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid. J Endocrinol. 148:1996;267-279.
13. Zurawski V R, Orjaseter H, Andersen A, Jellum E. Elevated serum CA-125 levels prior to diagnosis of ovarian neoplasia: Relevance for early detection of ovarian cancer. Int J Cancer. 42:1988;677-680.
14. Stenman U-H, Alfthan H, Vartiainen J, Lehtovirta P. Markers supplementing CA 125 in ovarian cancer. Ann Med. 27:1995;115-120.
15. Eerdekens M W, Nouwen E J, Pollet D E, Briers T W, DeBroe M E. Placental alkaline phosphatase and cancer antigen 125 in sera of patients with benign and malignant diseases. Clin Chem. 31:1985;687-690.
16. Barbieri R L, Niloff J M, Bast R C Jr., Schaetzl E, Kistner R W, Knapp R C. Elevated serum concentrations of CA 125 in patients with advanced endometriosis. Fertil Steril. 45:1986;630-634.
17. Halila H, Stenman U H, Seppala M. Ovarian cancer antigen CA 125 in pelvic inflammatory disease and pregnancy. Cancer. 57:1986;1327-1329.
18. Schwartz P E, Taylor K JW. Is early detection of ovarian cancer possible. Ann Med. 27:1995;519-528.
19. Lambert-Messerlian G M, Steinhoff M, Zheng W, Canick J A, Gajewski W H, Seifer D B, Schneyer A L. Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer. Gynecol Oncol. 65:1997;512-515.
20. Healy D L, Burger H G, Mamers P, Jobling T, Bangah M, Quinn M, Grant P, Day A J, Rome R, Campbell J J. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N Engl J Med. 329:1993;1539-1542.
21. Burger H G, Robertson D M, Cahir N, Mamers P, Healy D L, Jobling T, Groome N. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumors. Clin Endocrinol. 44:1998;413-418.
22. Flemming P, Grothe W, Maschek H, Petry K U, Wellmann A, Georgii A. The site of inhibin production in ovarian neoplasms. Histopathology. 29:1996;465-468.